• P. Bulet, Strasbourg:
  Use of MALDI-TOF mass spectrometry to reveal novel immune-induced peptides in Drosophila (30 min)
• H. Steiner, Stockholm:
  Application of differential display PCR techniques to unravel immunity genes (30min)

• S. Natori, Tokyo:
  Glutathion-linked antimicrobial peptides from flies (30 min)
• I.F. Nes, Akerhus, Norway:
  Ribosomally synthesised antimicrobial peptides in bacteria : A defense system used by bacteria to survive in a competitive environment? (30 min)
• D. Romeo, Trieste:
  Comparative studies on cathelicidins and other antimicrobial peptides for the design of efficient antibiotics (30 min)

Self-service coffee during the session

• R.I. Lehrer, Los Angeles:
  Antimicrobial peptides in human body fluids (50 min)
• C. Bevins, Cleveland:
  Regulation of antimicrobial peptide synthesis in mammals in response to bacterial stimuli (50 min)

• J.A. Hoffmann, Strasbourg:
  Antimicrobial peptides in insect immunity (50 min)

• F.C. Kafatos, Heidelberg:
  Innate immunity and transmission of parasites by vector insects (50 min)
• A.J. Ouellette, Irvine:
  Role of antimicrobial peptides in intestinal defense (50 min)

Self-service coffee during the session

• D.F. Klessig, Piscataway:
  Signaling in the plant defense response (50 min)
• W. Broekaert, Leuven:
  Antimicrobial peptides in plant immunity (50 min)

• F. Bazan, Palo Alto:
  A family of human receptors structurally related to Drosophila Toll (50 min)
• B. Beutler, Dallas:
  Positional cloning of LPS, the principal susceptibility locus for Gram negative sepsis (50 min)
• S. Akira, Hygo:
  MyD88 and TLR-4 KO mice are LPS-hyporesponsive

• E.A. Groisman, St Louis:
  Bacterial resistance to antimicrobial peptides (50 min)
• P. Rodriguez-Palenzuela, Madrid:
  Bacterial resistance to plant antimicrobial peptides (30 min)
• S.I. Miller, Seattle:
  Lipid A modifications and bacterial inducible resistance to antimicrobial peptides (30 min)

• R.E.W. Hancock, Vancouver:
  Design of improved antimicrobial peptides from natural templates 50min
• D. Aunis, Strasbourg:
  New antibacterial peptides involved in neuroimmunity in mammals 50min

• Y. Shai, Rehovot:
  Molecular basis for cell selectivity by antimicrobial peptides (50 min)
• H.G. Sahl, Bonn:
  The mode of action of lantibiotics. (50 min)

• W.M. Shafer, Atlanta:
  A proton motive force-driven efflux pump that recognizes antibacterial peptides (30 min)
• P.H. Axelsen, Philadelphia:
  Membrane recognition by antimicrobial peptides (50 min)

• M.A. Zasloff, Philadelphia:
  State of the art in commercial peptide applications (30 min)
• J. Fiddes, Sunnyvale:
  Medical uses of protegrin-like peptides (30 min)

• P.R. Abraham, Amsterdam:
  Therapeutic potential of designer antimicrobial peptides in pre-clinical models of infection (30 min)
• B. Simons, Leiden:
  Antifungal proteins in fungal resistance strategies for plants (30 min)
• J.M. Jaynes, Demeter:
  In vivo activity of designed antimicrobial peptides (30 min)
• Round table discussion and business meeting
  Chair: J.A. Hoffmann, Strasbourg